|
NL8220041A
(nl)
|
1981-01-14 |
1983-01-03 |
Knickerbocker Michael G |
Klepsamenstel met geintegreerde kunststofveer.
|
|
US4714681A
(en)
|
1981-07-01 |
1987-12-22 |
The Board Of Reagents, The University Of Texas System Cancer Center |
Quadroma cells and trioma cells and methods for the production of same
|
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
GB2183662B
(en)
|
1985-04-01 |
1989-01-25 |
Celltech Ltd |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
JPS63212525A
(ja)
|
1987-02-28 |
1988-09-05 |
Nissei Plastics Ind Co |
型締装置
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
DE68921982D1
(de)
|
1988-06-14 |
1995-05-04 |
Cetus Oncology Corp |
Kupplungsmittel und sterisch gehinderte, mit disulfid gebundene konjugate daraus.
|
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
|
US5223426A
(en)
*
|
1988-12-15 |
1993-06-29 |
T Cell Sciences, Inc. |
Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
IE63847B1
(en)
|
1989-05-05 |
1995-06-14 |
Res Dev Foundation |
A novel antibody delivery system for biological response modifiers
|
|
AU641673B2
(en)
|
1989-06-29 |
1993-09-30 |
Medarex, Inc. |
Bispecific reagents for aids therapy
|
|
ATE139258T1
(de)
|
1990-01-12 |
1996-06-15 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
|
EP0521985B1
(en)
|
1990-03-20 |
1997-09-24 |
The Trustees Of Columbia University In The City Of New York |
Chimeric antibodies with receptor binding ligands in place of their constant region
|
|
WO1992005793A1
(en)
|
1990-10-05 |
1992-04-16 |
Medarex, Inc. |
Targeted immunostimulation with bispecific reagents
|
|
EP0557300B1
(en)
|
1990-10-29 |
1997-11-19 |
Chiron Corporation |
Bispecific antibodies, method of production, and uses thereof
|
|
EP0574395B1
(en)
|
1990-11-09 |
2002-06-12 |
GILLIES, Stephen D. |
Cytokine immunoconjugates
|
|
ES2093778T3
(es)
|
1991-04-26 |
1997-01-01 |
Surface Active Ltd |
Nuevos anticuerpos y metodos para su uso.
|
|
WO1993017715A1
(en)
|
1992-03-05 |
1993-09-16 |
Board Of Regents, The University Of Texas System |
Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US20020064528A1
(en)
|
2000-01-28 |
2002-05-30 |
Zhenping Zhu |
Antibodies specific to KDR and uses thereof
|
|
US20020102208A1
(en)
|
1999-03-01 |
2002-08-01 |
Paul Chinn |
Radiolabeling kit and binding assay
|
|
US6849425B1
(en)
|
1999-10-14 |
2005-02-01 |
Ixsys, Inc. |
Methods of optimizing antibody variable region binding affinity
|
|
WO2002102855A2
(en)
|
2000-11-17 |
2002-12-27 |
University Of Rochester |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
|
US7319139B2
(en)
|
2001-01-29 |
2008-01-15 |
Biogen Idec, Inc. |
TAG-72 specific CH2 domain deleted antibodies
|
|
CN1671416B
(zh)
|
2001-07-12 |
2013-01-02 |
杰斐逊·富特 |
超人源化抗体
|
|
US20030020733A1
(en)
|
2001-07-24 |
2003-01-30 |
Yin Memphis Zhihong |
Computer display having selective area magnification
|
|
WO2003068819A1
(en)
*
|
2001-12-22 |
2003-08-21 |
4-Antibody Ag |
Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
|
|
JP2013534515A
(ja)
*
|
2010-06-01 |
2013-09-05 |
モナシュ ユニバーシティ |
プロセシングされていない受容体型チロシンキナーゼｃ−ＭＥＴに対する抗体
|
|
EP2611832B1
(en)
*
|
2010-09-02 |
2017-11-29 |
Vaccinex, Inc. |
Anti-cxcl13 antibodies and methods of using the same
|
|
WO2013074916A1
(en)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
TWI745610B
(zh)
*
|
2012-11-14 |
2021-11-11 |
美商再生元醫藥公司 |
重組細胞表面捕捉蛋白質
|
|
US9505849B2
(en)
*
|
2013-03-15 |
2016-11-29 |
Amgen Research (Munich) Gmbh |
Antibody constructs for influenza M2 and CD3
|
|
WO2014186469A2
(en)
|
2013-05-14 |
2014-11-20 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
HK1223943A1
(zh)
|
2013-05-24 |
2017-08-11 |
Board Of Regents, The University Of Texas System |
嵌合的靶向抗原受体的单克隆抗体
|
|
KR20160068960A
(ko)
|
2013-10-25 |
2016-06-15 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
면역요법을 위한 다클론성 감마 델타 t 세포
|
|
RU2753965C2
(ru)
|
2014-02-14 |
2021-08-24 |
Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем |
Химерные антигенные рецепторы и способы их получения
|
|
WO2015164594A1
(en)
|
2014-04-23 |
2015-10-29 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) for use in therapy and methods for making the same
|
|
AU2015249371B2
(en)
|
2014-04-24 |
2020-04-30 |
Board Of Regents, The University Of Texas System |
Application of induced pluripotent stem cells to generate adoptive cell therapy products
|
|
US10570186B2
(en)
|
2014-11-05 |
2020-02-25 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (CAR) to selectively target protein complexes
|
|
US20170333480A1
(en)
|
2014-11-05 |
2017-11-23 |
Board Of Regents, The University Of Texas System |
Gene modified immune effector cells and engineered cells for expansion of immune effector cells
|
|
JP6947647B2
(ja)
|
2015-02-24 |
2021-10-13 |
ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System |
遺伝子改変ｔ細胞の選択方法
|
|
RU2020127887A
(ru)
|
2015-03-11 |
2020-10-02 |
Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем |
Полипептиды транспозазы и их применение
|
|
US10633445B2
(en)
|
2015-09-15 |
2020-04-28 |
Board Of Regents The University Of Texas System |
T-cell receptor (TCR)-binding antibodies and uses thereof
|
|
WO2017075147A1
(en)
|
2015-10-27 |
2017-05-04 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor molecules and uses thereof
|